<DOC>
	<DOCNO>NCT01942213</DOCNO>
	<brief_summary>This open-label , Phase IV prospective , observational study evaluate patient , diagnose Neovascular Age-Related Macular Degeneration previously receive either standard intravitreal injection ranibizumab aflibercept , order get compare information regard post-injection inflammatory ( irritation eye ) 2-3 day post-injection . Additionally , patient evaluate visual acuity pain 2-3 day post-injection .</brief_summary>
	<brief_title>Observational Study Evaluate Compare Rate Extent Inflammation After Single Intravitreal Injection Ranibizumab vs. Single Intravitreal Injection Aflibercept Treatment Naive Treatment Experienced Patients .</brief_title>
	<detailed_description>Patients , age 65 90 , Neovascular Age-Related Macular Degeneration present treatment intravitreal ranibizumab aflibercept select study . 300 subject one site United States enrol . Inclusion Criteria : - Ability provide write informed consent comply study - Age 65-90 year - Diagnosis Neovascular Age-Related Macular Degeneration present treatment intravitreal ranibizumab aflibercept Exclusion Criteria : - Previous intraocular inflammation - Treatment systemic anti-inflammatory agent - Known systemic autoimmune diseases - Treatment intraocular steroid past 3 month - History intraocular surgery past 3 month - Age great 90 year - Patients switch either therapy past 3 month</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Ability provide write informed consent comply study assessment full duration study Age 6590 year Diagnosis Neovascular AgeRelated Macular Degeneration present treatment intravitreal ranibizumab aflibercept Previous intraocular inflammation Treatment systemic antiinflammatory agent Known systemic autoimmune disease Treatment intraocular steroid past 3 month History intraocular surgery past 3 month Age great 90 year Patients switch either therapy past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Macular</keyword>
	<keyword>Degeneration</keyword>
	<keyword>Age relate</keyword>
	<keyword>Neovascular</keyword>
</DOC>